A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
NCT 07064122 Brief Summary The purpose of the study to evaluate the…
Read more arrow_forwardNCT 07064122 Brief Summary The purpose of the study to evaluate the…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardACTRN 12621000223831 Brief Summary This study is investigating the efficacy of assigning…
Read more arrow_forwardNCT 06179511 Brief Summary This is a modular, multicentre, open-label, Phase I/II,…
Read more arrow_forwardACTRN 12625000160437 Brief Summary This study aims to evaluate the feasibility and…
Read more arrow_forward